Tate & Lyle takeover generates £163m fees bonanza for the City

The £2.7 billion takeover of Tate & Lyle by Ingredion has been greeted in the Square Mile with the sort of quiet satisfaction that rarely makes it into the deal announcement. For London’s advisers, it is not simply another transatlantic acquisition; it is a reminder of how reliably a large public-company transaction can translate into billable hours, underwriting risk, and a long chain of ancillary work that runs from boardroom to courtroom to the public markets. When the dust settles, bankers, lawyers and communications teams stand to share a pool of fees and expenses worth up to £163 million.

The arithmetic of modern M&A is unforgiving and, from the adviser’s point of view, elegantly simple. A deal of this size needs financial advisers to shepherd the target through its duties to shareholders, to negotiate price and protections, and to manage the choreography of a listed-company process. It needs the buyer’s advisers to structure financing and map regulatory and legal exposure. It needs lawyers to draft, negotiate and police every stage of that process. It needs communications specialists to shape the message for investors, employees, customers and politicians. Multiply that by two jurisdictions and two corporate cultures and it becomes clear why the fee line item can begin to look like an industry in its own right.

Ingredion, the Illinois-based manufacturer of starches and sweeteners, has secured the approval of Tate & Lyle’s board for a 595p-per-share cash offer. The company being acquired is 165 years old, and though Tate & Lyle has long since been transformed from the sugar titan of popular memory into a global supplier of food and beverage ingredients to industrial markets, the name still carries an unmistakable London resonance. It is also, as the market has been reminded, the last remaining original constituent of the FT30, the stock market index formed in 1935 and predecessor of the FTSE indices that now frame Britain’s equity culture. In that sense, this is both an industrial deal and a small moment of market history.

The offer price represents a 58.7 per cent premium to Tate & Lyle’s undisturbed closing share price of 374¾ on May 13. Premiums of this size are designed to do several jobs at once: to persuade shareholders that a clean cash exit is preferable to the uncertainties of future growth, to signal seriousness and reduce the risk of a competing bid, and to give the target board enough cover to recommend acceptance without appearing to have settled too quickly. The premium also speaks, indirectly, to the buyer’s confidence that value can be extracted once the two businesses are combined, whether through greater scale, cost efficiencies, or a clearer strategic focus. None of that is guaranteed, but the price tells you what has to be believed for the deal to make sense.

On Tate & Lyle’s side, the bill is set to run to as much as £64.2 million. Financial and corporate broking advice will cost £40.3 million, to be shared between Goldman Sachs and Greenhill, the lead banking advisers, and Bank of America and Citigroup, which were appointed joint financial advisers and corporate brokers. In parallel, Linklaters will receive legal fees worth £22 million. FTI Consulting, the City communications firm, is set to earn up to £1 million on the close of the transaction.

Ingredion’s side carries a larger headline number: fees and expenses of up to $132.3 million. That figure includes finance fees of $44.1 million and investment banking fees of up to $34 million for JPMorgan, the buyer’s sole financial adviser. Hogan Lovells is set to receive $19.9 million in legal fees. The remaining costs are reserved for public relations firms, accountants and the stamp duty costs tied to the transaction. JPMorgan has provided Ingredion with a bridging facility worth $4.2 billion to help fund the takeover and its associated expenses.

Fee disclosures like these are often treated as colourful detail, a way of counting winners and losers after the main event. In fact they are central to how deals are assembled and sold. Advisers are paid not only for advice but for assuming responsibility, in reputational terms, for the work they sign off: fairness opinions, valuation work, the shaping of the offer, and the judgements that determine whether boards can defend their decisions to shareholders and regulators. Lawyers are paid not only for drafting but for anticipating what can go wrong: conditions, termination rights, disclosure obligations, and litigation risk. Communications consultants are paid not only to announce but to manage the conversations that can derail a transaction, particularly when jobs, national icons or political sensitivities hover in the background.

Yet there is an undeniable tension in the spectacle of a nine-figure advisory pot alongside the rhetoric of corporate strategy. A takeover is typically justified in the language of customers and innovation, of scale and resilience. The fee tally sits awkwardly beside that story because it illustrates a parallel truth: modern corporate finance sustains a wide professional ecosystem whose interests are not identical to those of shareholders or employees. The work is real and, in complex transactions, often necessary. But the incentives are also plain. The more deals are done, the more everyone involved gets paid, even when the underlying industrial logic is contested and the distributional consequences are felt elsewhere.

This transaction lands at a moment when the deal pipeline has clearly thickened. Dealmakers are on course for bumper payouts this year, with the total value of transactions rising to $230.9 billion in the first six months of 2026, up 210 per cent on the same period in 2025. Those numbers do not, on their own, prove that the economy is healthier or that companies are making better long-term decisions. What they do show is that confidence, capital availability, and boardroom appetite for large moves have returned after a period when volatility and interest-rate shifts kept many teams on the sidelines.

It also reflects a familiar dynamic for London-listed companies, particularly those that are well-run but not necessarily celebrated by the market. A cash bidder can look at a share price that has not fully captured the potential of a niche industrial business and see an opportunity. Sterling valuations, the structure of the UK equity market, and a longstanding debate about whether London gives adequate credit to steady, specialist manufacturers all form part of the backdrop. It is not an argument that every departure is a loss, nor that every foreign buyer is predatory. But the steady drip of prominent takeovers forces the question of what sort of public market Britain wants to maintain, and what it is willing to do to keep companies listed and growing here.

Tate & Lyle’s own transformation is relevant. The company sold its sugar business in 2010, effectively severing the link with the product that made its name and refashioning itself around food and beverage ingredients. That shift places it in a global sector where scale, distribution, and long-term customer relationships matter, but where growth is also shaped by changing consumer preferences, regulation, and the constant push for reformulation and functional ingredients. The strategic case for a larger group absorbing Tate & Lyle is, on one reading, straightforward: consolidate complementary portfolios, broaden reach, and invest more heavily in product development and customer solutions than either could justify alone.

On another reading, the deal is a reminder that even companies with respected industrial positions can struggle to command full value as stand-alone listed entities when investor attention is scarce and the market prefers more easily narrated growth stories. A premium of 58.7 per cent is, in that context, a comment on the gap between what the market was prepared to pay and what a strategic buyer believes the assets are worth in its own hands. Shareholders may welcome the uplift. Management teams may privately accept that the public market was not offering a sufficiently patient valuation. Critics may argue that the premium is as much an indictment of the market as it is evidence of superior strategy.

The financing side adds another layer. The bridging facility of $4.2 billion supplied by JPMorgan underlines both the scale of the funding needed and the role banks play in underwriting certainty for buyers. Bridge financing is designed to ensure that a bidder can complete a transaction even while longer-term funding is arranged. It also represents a form of confidence in the buyer’s ability to refinance under acceptable terms. That confidence can be well-founded, but it is not costless. Fees for financing, as flagged in Ingredion’s projected expense list, are part of the broader price of doing business at this level.

For advisers, the Tate & Lyle transaction is a textbook example of how a major deal becomes a multi-disciplinary project. The presence of multiple banks on the target side reflects both the demands of corporate broking and the need for a target board to demonstrate it has taken extensive, independent advice. The distribution of roles, with Goldman Sachs and Greenhill in the lead and Bank of America and Citigroup appointed joint advisers and corporate brokers, is a familiar structure. Legal fees of the scale disclosed for Linklaters indicate both the workload and the premium attached to top-tier counsel in a transaction with significant disclosure obligations and cross-border considerations. A relatively modest figure for communications consultancy still signals that narrative management is now a standard part of the package, not a discretionary extra.

There is, however, a wider point about what these fees say about the balance of power in corporate Britain. In an idealised version of capitalism, capital flows to its most productive uses, and intermediaries are paid enough to facilitate that flow without becoming the main beneficiaries. In the real world, the intermediaries are often the best organised, the most protected from downside, and the quickest to crystallise value. Advisers are paid whether a merger ultimately produces the efficiencies promised in the presentation deck. Shareholders take the risk of reinvestment or the opportunity cost of selling. Employees take the risk that “synergies” translate into redundancies. Communities take the risk that a headquarters function is hollowed out. None of that is inevitable in this deal, but it is inseparable from how large acquisitions are typically pursued.

At the same time, it would be glib to treat the advisory industry as mere rent extraction. Cross-border takeovers of public companies are legally and financially complex. Missteps can destroy value quickly, from regulatory delays to shareholder lawsuits to financing hiccups that spook the market. Paying for competent advice can be rational insurance. What makes the fee numbers striking is not that professionals are paid, but the scale at which corporate transactions now operate and the degree to which the architecture of a deal, rather than the underlying business, can dominate the immediate economic consequences.

The loss of Tate & Lyle as a listed London name will be felt most symbolically through its FT30 status, a reminder of how the market has changed over generations. Index constituents come and go; companies evolve, merge, and disappear. Yet symbolism matters in finance because it shapes confidence, and confidence shapes whether capital chooses to list, raise money and grow in a particular market. Each high-profile acquisition feeds an argument, already loud in policy circles, about whether London is becoming a marketplace where mature companies are more likely to be sold than to scale independently.

For Tate & Lyle shareholders, the immediate question is narrower: whether 595p properly reflects the prospects of the company and the risks ahead. A cash offer at a substantial premium can look compelling, particularly if the prior market price was depressed by uncertainty or a lack of enthusiasm for the sector. For Ingredion, the question is whether the strategic logic survives the realities of integration, customer retention, and execution, and whether the price still looks sensible once financing costs and the practical frictions of consolidation are absorbed.

For the City, the answer is more immediate and less philosophical. A £163 million pool of fees and expenses is an unmistakable sign that the deal machine is running hot again. When transaction values jump as they have in the first half of 2026, the beneficiaries are not confined to the companies doing the buying and selling. They spread through a professional services complex that has become, in effect, one of Britain’s quiet export industries, selling expertise and process to capital on the move. The Tate & Lyle takeover, with its blend of history, premium pricing, and lavish advisory economics, is a neat snapshot of that system at work.